AbbVie Inc. - Depositary Receipt (ABBV)
BCBA
Real-time Data
02:00 PM
Day's Range
41,540.0052 wk Range
27,300.00Overview - ABBV - AbbVie Inc. - Depositary Receipt
Key Statistics
Valuation
Enterprise Value
111,868.13T
P/E (Trailing)
‪7.97‬
PEG Ratio
‪0.02‬
Price / Sales (TTM)
‪1,159.85‬
Price / Book
‪-12,696.66‬
EV / EBITDA
‪2,429.63‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪9.80%‬
Operating Margin
‪40.03%‬
Return on Assets
‪10.51%‬
Return on Equity
‪-129.67%‬
Ownership
Shares Outstanding
1.76B
Float
1.76B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪38,980.80‬
200-Day Avg
‪34,363.10‬
Dividends
Payout Ratio
‪19.04%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ABBV - AbbVie Inc. - Depositary Receipt
Peers - ABBV - AbbVie Inc. - Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
Profile Summary - ABBV - AbbVie Inc. - Depositary Receipt
About
AbbVie Inc. - Depositary Receipt is an unsponsored depositary receipt representing common stock of AbbVie Inc., a global biopharmaceutical company. It enables investors in specific markets to gain exposure to AbbVie's shares without direct ownership on the primary exchange. AbbVie Inc. focuses on discovering,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
